What Facidex Treats: Main Uses and Benefits

Facidex is used for the short-term management of symptoms associated with common acid-related discomfort.

The medication is primarily utilized to manage the symptomatic discomfort of acid indigestion and heartburn (pyrosis), including sour stomach and nocturnal acid flare-ups. It is generally applicable for conditions characterized by episodic or fluctuating manifestations, particularly during phases when symptoms become more noticeable due to dietary factors or temporary physiological stress.

Facidex may be used for easing symptoms that create noticeable physiological strain in the upper digestive tract. By addressing this specific discomfort, the medicine contributes to improved comfort during periods of heightened symptoms and supports general well-being during symptomatic phases, especially when symptoms interfere with daily functioning or rest.

Quick Fact: Relief for Acid Discomfort
Primary Symptoms	Heartburn, Acid Indigestion, Sour Stomach
Context of Use	Episodic or recurrent flare-ups
General Benefit	Support for managing symptomatic distress

Regulatory References

1. NIH DailyMed Drug Label

Who Can and Cannot Use Facidex?

Facidex eligibility is defined by official regulatory labeling and is based on age, physiological state, and existing medical conditions.

---

Populations Allowed and Restricted

Category	Regulatory Status
Approved Age	Allowed for Adults and Adolescents/Children ge 12 years for short-term, symptomatic relief.
Pediatric Use	Safety and effectiveness have not been established in children younger than 12 years.
Older Adults	Use requires caution due to increased sensitivity to central nervous system (CNS) effects.
Renal Impairment	Patients with non-severe renal impairment must consult a physician due to the risk of active substance accumulation.
Pregnancy	Not recommended unless the potential benefit justifies the risk; requires consultation with a health professional.
Lactation	Not recommended as the drug is excreted in breast milk; requires consultation with a health professional.

---

Absolute Contraindications

Use of Facidex is strictly contraindicated in several groups:

• Patients with known hypersensitivity to any of the active ingredients (Famotidine, Calcium Carbonate, Magnesium Hydroxide) or other H2-receptor antagonists (cross-sensitivity).
• Individuals with severe renal failure.
• Individuals who are concurrently using other acid reducers.

---

Self-Medication Exclusion

Eligibility for self-medication is revoked if serious symptoms are present. Individuals should not use Facidex if experiencing trouble swallowing food, vomiting blood, bloody or black stools, or chest pain accompanied by light-headedness or sweating, as these symptoms require immediate medical attention.

Facidex (famotidine, an H2-receptor antagonist) can interact with a range of other medicines and products. These interactions primarily occur in two ways: by altering the body's metabolism of the interacting medicine or by changing how well certain medicines are absorbed due to the decrease in stomach acid.

Reduced Absorption

By raising the pH level in the stomach, Facidex can decrease the absorption and effectiveness of medicines that require an acidic environment to dissolve properly. These include certain antifungal agents (like ketoconazole and itraconazole), some HIV/AIDS medications (such as atazanavir), and a few targeted cancer drugs (like erlotinib and dasatinib).

Altered Metabolism

Some medicines are broken down more slowly by the body when taken with Facidex, which can lead to increased levels of the interacting medicine in the bloodstream and a higher risk of side effects. This is particularly relevant for tizanidine (a muscle relaxant) and warfarin (a blood thinner), where close monitoring is necessary. Other drugs whose levels may be affected include phenytoin and certain beta-blockers.

Other Important Interactions

• Antacids: While antacids can be used for relief as needed, they should not be taken at the exact same time as Facidex, as they may interfere with its absorption. Separate the doses by at least two hours.
• Vitamin B12 and Minerals: Long-term use may impair the absorption of Vitamin B12 and some minerals, such as iron and calcium.

It is essential to inform your healthcare provider of all prescription, over-the-counter, and herbal supplements you are taking before starting treatment with Facidex.

Blocking the Histamine Signal at H2 Receptors

Facidex acts as a competitive antagonist by binding selectively to the histamine-2 ( H2) receptors found on the stomach's parietal cells. This primary action interrupts the upstream molecular signal, preventing histamine from stimulating the cell to produce acid.

---

Interruption of the Intracellular Acid Cascade

By blocking the H2 receptor, Facidex inhibits the subsequent internal signaling cascade, specifically by reducing the synthesis of the secondary messenger cAMP (cyclic adenosine monophosphate). This mechanistic step limits the activation signal that flows to the final proton pumps ( H^+/ K^+-ATPase) within the cell.

---

Modulating Gastric Secretion and Acidity

The overall physiological consequence of the mechanism is a reduction in the activity of the proton pumps, which leads to a decrease in the volume and the concentration of hydrogen ions ( H^+) in the stomach lumen. This mechanism modulates the physiological process of gastric acid secretion, resulting in an elevation of the pH within the stomach lumen.

How to use Facidex

The administration of Facidex follows a short-term, episodic protocol. This medicine is designed for oral administration and is supplied as a chewable tablet. The specific formulation combines a Histamine H2-Receptor Antagonist with alkaline antacids, a dual action that necessitates a particular intake method. The tablet must be chewed completely before swallowing to ensure the proper function of both the rapid-acting and sustained-action components.

Dosing and Frequency

The dosing is structured for both treatment and prevention. For the relief of existing symptoms, the standard dose is one tablet taken as needed. For preventative use, one tablet should be taken approximately one hour before consuming food or beverages that may trigger discomfort. Established guidelines specify a limit: an individual must not take more than two tablets within any 24-hour period.

Duration and Population Rules

Facidex is approved for use in adults and adolescents 12 years of age and older. There are specific use-context constraints, particularly for patients with coexisting conditions. For instance, individuals with kidney disease should seek medical advice prior to use, as a dosage adjustment may be required to manage systemic exposure. The medicine is designated for short-term use, and continuous administration must not exceed 14 days. Use beyond this two-week limit requires consultation with a healthcare professional to reassess the condition.

Research Evidence / Overview of Studies for Facidex

This section summarizes the structure of the clinical trials and research that has examined the combination of Famotidine, Calcium Carbonate, and Magnesium Hydroxide. It focuses solely on the types of studies conducted, the outcomes measured, and the limitations noted, to help contextualize how patients reported their experience.

---

1. Evidence for Use in Episodic Heartburn and Acid Indigestion

Research has primarily used short-term Randomized Controlled Trials (RCTs) in research exploring how symptoms change over time in conditions characterized by fluctuating or episodic manifestations. These studies monitored patient-reported outcomes describing perceived discomfort in conditions such as heartburn and acid indigestion. Research examined patient-reported outcomes, focusing on the time to and duration of relief reported by participants. Findings describe patterns observed in the studies used in research exploring how symptoms change over time.

---

2. Research on Time to Relief and Duration of Action

Dedicated studies were evaluated in research exploring short-term symptom changes and sustained activity of the combination product. This research explored short-term symptom changes, often using a single-dose approach to observe the response patterns of the two components within the body. In these trials, studies monitored outcomes capturing phases of heightened symptom activity, such as nocturnal acid flare-ups. Studies contribute to the broader evidence landscape, with research describing both rapid-onset and sustained-response patterns in these research scenarios.

---

3. Review of Evidence in Special Populations

The main research exploring short-term symptom changes was evaluated in a population consisting primarily of Adults and Adolescents (typically age 12 and older) who were generally healthy apart from their acid-related discomfort. Consequently, results apply only to the populations studied, meaning that data for certain groups remain insufficient. For instance, the research does not include sufficient data for older adults or individuals who also have significant pre-existing conditions, such as advanced kidney issues. Research does not determine whether an individual in one of these groups may respond similarly.

---

4. Understanding Long-Term Use and Follow-Up Data

The evidence was studied for short-term treatment phases, contributing to understanding symptom patterns in these research scenarios. Follow-up durations were limited in the core efficacy trials for this combination product, typically lasting only one to two weeks. Therefore, the long-term effects are not fully established, and there is limited information for long-term outcomes related to chronic, daily acid conditions over many months. Studies exploring outcomes related to chronic, daily acid conditions over an extended period are still emerging.

---

5. What Remains Uncertain About Facidex Research

Research describes how symptoms evolved in the observed populations, though evidence quality varies across studies and several limitations were observed in some studies. Sample sizes were modest in certain comparisons, and the follow-up durations were limited, as noted above. Because the trials focused on generally healthy adults experiencing simple, episodic heartburn, the results apply only to the populations studied. Additionally, while the combination was studied for its dual action, comparative evidence is lacking against other specific combination products, indicating that uncertainty about comparative findings exists.

Key Studies & References

1. Famotidine/Calcium Carbonate/Magnesium Hydroxide Combination Drug Label (DailyMed)
2. A Randomized Clinical Trial of Famotidine, Calcium Carbonate, and Magnesium Hydroxide Combination vs. Antacid Alone for Heartburn Relief
3. Famotidine (MedlinePlus Drug Information)

Common questions about Facidex (FAQ)

Q: Are there any known long-term side effects associated with Facidex use?

A: Official research supporting the product's short-term uses was typically conducted over limited durations. Consequently, specific data on outcomes related to chronic, daily administration are limited in the core efficacy trials, meaning the full range of long-term effects is not fully established.

Q: Can Facidex affect a patient's ability to drive or operate machinery?

A: Regulatory information indicates that caution may be warranted when engaging in tasks requiring concentration. This is because the drug can cause side effects such as dizziness or confusion (especially in older adults or those with kidney impairment), which may affect concentration or coordination.

Q: Does Facidex require any special monitoring or blood tests?

A: Official guidance suggests that special monitoring, such as blood and urine tests, may be considered by a healthcare provider for certain patients. This may be necessary to check for unwanted effects, especially if the patient has kidney disease or is taking the medicine for an extended period, due to potential mineral/vitamin absorption concerns.

Q: Are there any common herbal or dietary supplements that interact with Facidex?

A: Since Facidex changes the level of acidity in the stomach, it is known to interact with certain medicines and supplements whose absorption is affected. Official documents generally recommend disclosing all prescription and herbal products or supplements to a healthcare professional.

Q: Can Facidex be taken at the same time as my daily vitamins?

A: The official documentation states that extended periods of administration of the product may be associated with impaired absorption of certain vitamins and minerals. Specifically, regulatory information highlights concerns regarding Vitamin B12, iron, and calcium.

Q: Is Facidex a controlled substance?

A: No. Facidex, which contains famotidine, calcium carbonate, and magnesium hydroxide, is not classified as a controlled substance by U.S. regulatory bodies.

Q: Does Facidex interact with alcohol?

A: The ingredients used in the flavorings of the chewable tablet are typically formulated to not contain alcohol. The official labeling does not describe a specific interaction warning related to general alcohol consumption.

Q: Does Facidex have any major food restrictions listed in official documents?

A: Official prescribing information indicates that the medicine may be taken with or without food. There are no major food restrictions listed in the regulatory documents.

Q: Does Facidex cause weight gain or loss?

A: Weight change (gain or loss) is not listed among the common or frequently reported side effects in official regulatory product labeling for this combination medicine.

Q: Where can I find the official patient information leaflet (PIL) for Facidex?

A: Official patient information leaflets (PIL) or consumer documents can typically be found on the websites of regulatory bodies. These resources can typically be found on websites such as the NIH’s DailyMed and the FDA’s resources.

Q: Why does Facidex sometimes cause insomnia?

A: Trouble sleeping (insomnia) is listed as an uncommon or rare side effect in the regulatory documents for the active ingredient famotidine. This is a potential adverse event, though it is not frequently reported.

Q: Is Facidex a habit-forming medicine?

A: No. Official regulatory documents do not classify Facidex as a habit-forming or dependency-inducing substance.

Q: Does taking Facidex with food increase or decrease its absorption?

A: Regulatory information indicates that the medicine's absorption may be slightly increased by food. However, this finding is not considered to be a major factor in its therapeutic function.

Q: How long does Facidex typically stay in the body after the last dose?

A: The time it takes for a medicine to be eliminated is often described by its half-life. The average elimination half-life of the famotidine component is approximately 2.5 to 3.5 hours in adults with normal kidney function.

Q: What is the difference between Facidex tablets and Facidex capsules?

A: The official product labeling describes the medicine as available in both a chewable tablet and a standard tablet form. Regulatory documents do not mention a capsule form for this specific combination product.

Q: Is there a generic version of Facidex available?

A: Yes. The active ingredients—famotidine, calcium carbonate, and magnesium hydroxide—are available from multiple manufacturers as generic equivalents.

Q: What is the significance of the 'black box warning' on Facidex?

A: There is no Black Box Warning required for this specific combination product in its official regulatory labeling. This designation is only used for certain medicines that carry serious risks.

How to Store and Dispose of Facidex

Official regulatory documents mandate specific environmental and container conditions for the storage of Facidex (famotidine, calcium carbonate, and magnesium hydroxide) tablets to ensure product integrity.

Storage Requirements

Facidex must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F). The medicine must be protected from moisture and excessive heat and should be stored in a cool, dry place.

Storage Restriction	Requirement
Container	Keep in the original container and ensure it is tightly closed.
Stability	Do not use the tablets after the expiration date printed on the packaging.
Child Safety	Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Facidex must be disposed of according to local regulatory requirements for pharmaceutical waste. The medication should not be disposed of by flushing it down the toilet or pouring it into wastewater.